Simplex Trading’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-105,025
Closed -$2.14M 9803
2025
Q3
$1.43M Buy
105,025
+3,825
+4% +$39.8K ﹤0.01% 2678
2025
Q2
$823K Buy
101,200
+95,436
+1,656% +$815K ﹤0.01% 2979
2025
Q1
$45K Buy
5,764
+4,837
+522% +$56.1K ﹤0.01% 5881
2024
Q4
$13K Sell
927
-9,813
-91% -$160K ﹤0.01% 7022
2024
Q3
$164K Sell
10,740
-119,120
-92% -$1.88M ﹤0.01% 4718
2024
Q2
$1.98M Buy
129,860
+120,137
+1,236% +$1.94M ﹤0.01% 2214
2024
Q1
$183K Sell
9,723
-77,361
-89% -$1.34M ﹤0.01% 4953
2023
Q4
$1.66M Buy
87,084
+2,291
+3% +$36.6K ﹤0.01% 2517
2023
Q3
$1.52M Sell
84,793
-39,748
-32% -$799K ﹤0.01% 2310
2023
Q2
$2.53M Buy
124,541
+115,943
+1,348% +$2.21M ﹤0.01% 1786
2023
Q1
$156K Buy
+8,598
New +$164K ﹤0.01% 4617
2022
Q2
Sell
-195
Closed -$4.78K 10886
2022
Q1
$6K Buy
+195
New +$6.53K ﹤0.01% 9316
2021
Q4
Sell
-20,237
Closed -$785K 11265
2021
Q3
$557K Buy
20,237
+100
+0.5% +$3.11K ﹤0.01% 3923
2021
Q2
$552K Buy
+20,137
New +$575K ﹤0.01% 3993
2021
Q1
Sell
-24,769
Closed -$862K 9819
2020
Q4
$643K Buy
+24,769
New +$600K ﹤0.01% 3108
2019
Q4
Sell
-57
Closed -$479 7850
2019
Q3
$0 Buy
+57
New +$458 ﹤0.01% 7765

Other funds holding RCUS

Simplex Trading's RCUS Position: Q4 2025 in Review

Simplex Trading sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 105,025 shares — an estimated $2.14M sold.

Simplex Trading first reported a position in RCUS in Q3 2019 and held it in 16 quarters. The position peaked at $2.53M in Q2 2023. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Simplex Trading reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 105,025 Arcus Biosciences shares in Q4 2025, an estimated $2.14M.
  • Simplex Trading first reported a position in Arcus Biosciences in Q3 2019 and held it in 16 quarters.
  • Simplex Trading's Arcus Biosciences position peaked at $2.53M in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.